HollyHGallionMD

PubMed

• 13 citations
  Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy.
  Laura M Harbin, Holly H Gallion, Derek B Allison, Jill M Kolesar> ;Diagnostics. 2022 Mar 29
• 1 citations
  Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram.
  Justin W Gorski, Charles S Dietrich 3rd, Caeli Davis, Lindsay Erol, Hayley Dietrich, Nicholas J Per, Emily Lenk Ferrell, Anthony B McDowell, McKayla J Riggs, Megan L H...> ;Diagnostics. 2022 Jan 7
• 5 citations
  Ultrasonographic Visualization of the Ovaries to Detect Ovarian Cancer According to Age, Menopausal Status and Body Type.
  Edward J Pavlik, Emily Brekke, Justin Gorski, Lauren Baldwin-Branch, Rachel Miller, Christopher P DeSimone, Charles S Dietrich, Holly S Gallion, Frederick Rand Ueland,...> ;Diagnostics. 2022 Jan 6
• 16 citations
  Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
  Justin W. Gorski, Zhuwei Zhang, J. Robert McCorkle, Jodi M. DeJohn, Chi Wang, Rachel W. Miller, Holly H. Gallion, Charles S. Dietrich, Frederick R. Ueland, Jill M. Kol...> ;Biomedicines. 2021 Aug 1
• 15 citations
  MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer.
  Megan L. Hutchcraft, Holly H. Gallion, Jill M. Kolesar> ;Diagnostics. 2021 Jan 6
• Clinicopathological effects of body composition measurements for patients with endometrial cancer.
  Christopher G. Smith, Deepti Sharma, Hagen Smith, Shelley Zippay, Liza Bastin, Luis Acosta-Briceno, James T. Lee, Brent J. Shelton, Justin W. Gorski, Anthony McDowell,...> ;Minerva Ginecologica. 2021 Jan 1
• 9 citations
  Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness
  Edward J. Pavlik, Christopher G. Smith, Taylor S. Dennis, Elizabeth Harvey, Bin Huang, Quan Chen, Dava West Piecoro, Brian T. Burgess, Anthony McDowell, Justin W. Gors...> ;Diagnostics. 2020 Jan 21
• 4 citations
  Inherited alterations of TGF beta signaling components in Appalachian cervical cancers
  Thomas J. Knobloch, Juan Peng, Erinn M. Hade, David E. Cohn, Mack T. Ruffin, Michael A. Schiano, Byron C. Calhoun, William C. McBee, Jamie L. Lesnock, Holly H. Gallion...> ;Cancer Causes & Control. 2019 Aug 21
• 8 citations
  Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
  Christopher G. Smith, Daniel L. Davenport, Justin W. Gorski, Anthony McDowell, Brian T. Burgess, Tricia I. Fredericks, Lauren A. Baldwin, Rachel W. Miller, Christopher...> ;Healthcare. 2019 Jul 3
• 11 citations
  Teaching gynecologic oncology in Low resource settings: a collaboration of health volunteers overseas and the society of gynecologic oncology.
  Linus Chuang, Kathleen N. Moore, William T. Creasman, Annekathryn Goodman, Hoover Henriquez Cooper, F.V. Price, Michael G. Conner, Vishal Gupta, Holly H. Gallion, Nade...> ;Gynecologic Oncology. 2014 Dec 1
• 59 citations
  Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherap...
  Chunqiao Tian, Christine B. Ambrosone, Kathleen M. Darcy, Thomas C. Krivak, Deborah K. Armstrong, Michael A. Bookman, Warren Davis, Hua Zhao, Kirsten B. Moysich, Holly...> ;Gynecologic Oncology. 2012 Mar 1
• 30 citations
  Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinom...
  Thomas C. Krivak, Kathleen M. Darcy, Chunqiao Tian, Michael A. Bookman, Holly H. Gallion, Christine B. Ambrosone, Julie A. DeLoia> ;Gynecologic Oncology. 2011 Jul 1
• 4 citations
  Consistency of in vitro chemoresponse assay results and population clinical response rates among women with endometrial carcinoma.
  Warner K. Huh, Michael L. Cibull, Holly H. Gallion, Christine M. Gan, Scott D. Richard, David E. Cohn> ;International Journal of Gynecological Cancer. 2011 Apr 1
• 23 citations
  Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer? A gynecologic o...
  Kathleen N. Moore, Chunqiao Tian, D. Scott McMeekin, J. Tate Thigpen, Marcus E. Randall, Holly H. Gallion> ;Cancer. 2010 Dec 1
• 19 citations
  Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
  John H. Farley, Chunqiao Tian, G. Scott Rose, Carol L. Brown, Michael J. Birrer, John I. Risinger, J. Tate Thigpen, Gini F. Fleming, Holly H. Gallion, G. Larry Maxwell> ;Cancer. 2010 Jan 15
• 3 citations
  Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study
  Ronald D. Alvarez, Robert S. Mannel, Agustin A. Garcia, Holly H. Gallion, Joseph A. Lucci, Larry C. Kilgore, T. M. Numnum, Sharon Xiaohan Zou, Mauro Orlando, Datchen F...> ;Gynecologic Oncology. 2009 Dec 1
• 58 citations
  Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cis...
  Thomas C. Krivak, Kathleen M. Darcy, Chunqiao Tian, Deborah K. Armstrong, Bora E. Baysal, Holly H. Gallion, Christine B. Ambrosone, Julie A. DeLoia> ;Journal of Clinical Oncology. 2008 Jul 20
• 30 citations
  Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.
  Zhibao Mi, Frankie A. Holmes, Beth A. Hellerstedt, John Pippen, Rufus P. Collea, Amanda Backner, Jason E. Bush, Holly H. Gallion, Alan Wells, Joyce O'Shaughnessy> ;Anticancer Research. 2008 May 1
• 16 citations
  Expression and activity of taxane-metobolizing enzymes in ovarian tumors
  Julie A. DeLoia, William C. Zamboni, Jacqueline M. Jones, Sandra Strychor, Joseph L. Kelley, Holly H. Gallion> ;Gynecologic Oncology. 2008 Feb 1
• 2 citations
  Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
  Allison E. Axtell, Joseph L. Kelley, Amanda N. Fader, Dilip Gupta, Benjamin M Schwartz, John T. Comerci, Yan Lin, Samuel Weiand, Holly H. Gallion, Amal Kanbour-Shakir> ;Gynecologic Oncology. 2007 Dec 1
• 115 citations
  The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Onc...
  D. Scott McMeekin, Virginia L. Filiaci, J. Tate Thigpen, Holly H. Gallion, Gini F. Fleming, William H. Rodgers> ;Gynecologic Oncology. 2007 Jul 1
• 110 citations
  Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer
  Melissa M. Thrall, Julie A. DeLoia, Holly H. Gallion, Norbert Avril> ;Gynecologic Oncology. 2007 Apr 1
• 46 citations
  Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: A Gynecologic Oncology Group study
  Susan C. Modesitt, Chunqiao Tian, Richard Kryscio, J. Tate Thigpen, Marcus E. Randall, Holly H. Gallion, Gini F. Fleming> ;Gynecologic Oncology. 2007 Apr 1
• 81 citations
  Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
  G. Larry Maxwell, Chunqiao Tian, John I. Risinger, Carol L. Brown, G. Scott Rose, J. Tate Thigpen, Gini F. Fleming, Holly H. Gallion, Wendy R. Brewster> ;Cancer. 2006 Nov 1
• 62 citations
  BRCA1 expression in a large series of sporadic ovarian carcinomas: A Gynecologic Oncology Group study
  Melissa M. Thrall, Holly H. Gallion, R. Kryscio, M. Kapali, Deborah K. Armstrong, Julie A. DeLoia> ;International Journal of Gynecological Cancer. 2006 Feb 1
• Join now to see all